Suppr超能文献

聚核苷酸高能量疗法治疗术后萎缩性凹陷性瘢痕的探索性研究

An Exploratory Study of PN HPT for Treating Postsurgical Atrophic and Depressed Scars.

作者信息

Araco Antonino, Araco Francesco, Raichi Mauro

机构信息

Cosmetic and Plastic Surgeon, Aesthetic Medicine Department, Tor Vergata University, Rome, Italy.

Cosmetic and Plastic Surgeon, San Giovanni Evangelista Hospital, Tivoli, Italy.

出版信息

J Cosmet Dermatol. 2025 Jan;24(1):e16764. doi: 10.1111/jocd.16764.

Abstract

BACKGROUND

Postsurgical atrophic scars tend to respond poorly to treatments, especially non-energy-based ones. Hydrophilic PN HPT (Polynucleotides High Purification Technology) injected intradermally is a non-energy-based option with an immediate volume-enhancing effect that indirectly improves the fibroblast synthesis of collagen and extracellular matrix. The PN HPT ingredient has the further benefit of a dermal "priming" effect that enhances the efficacy of other scar treatments.

OBJECTIVES

Verify retrospectively, with advanced techniques, the efficacy of PN HPT monotherapy as postsurgical scar treatment.

METHODS

Retrospective data collection in 18- to 65-year-old women with moderate-to-severe atrophic scars after mammary surgery undergoing a five-session intradermal treatment course with 0.75% PN HPT gel formulation in single-use syringes starting 6 months after surgery. Primary retrospective efficacy parameter: changes in scar morphology and symptom severity after three and 6 months (modified Vancouver Scar Scale, mVSS). Secondary efficacy parameters: roughness score 6 months after baseline (Antera 3D CS tridimensional skin analysis system) and Global Aesthetic Improvement Scale (GAIS, Investigator and Patient subscales) after three and 6 months.

RESULTS

Total mean mVSS highly significantly improved from 11.2 ± 1.92 at baseline to 7.0 ± 1.68 and 6.9 ± 1.55 after three and 6 months, respectively; the mean Antera 3D CS roughness score improved from 13.5 ± 4.14 to 10.0 ± 3.49 after 6 months. After three and 6 months, the GAIS subscores for investigators and cohort subjects were identical (3.0 ± 0.81 and 3.0 ± 0.72, respectively). The photographic documentation supported the previous results.

CONCLUSIONS

In monotherapy, the intradermal PN HPT ingredient seems to quickly and safely relieve the burden of postsurgical atrophic scars. However, the lack of a formal parallel control group is a severe limitation. The objective quantitative measurements confirmed the long-lasting benefits.

摘要

背景

术后萎缩性瘢痕对治疗的反应往往较差,尤其是非能量型治疗。皮内注射亲水性多核苷酸高纯化技术(PN HPT)是一种非能量型治疗方法,具有即刻增加容积的效果,可间接改善成纤维细胞合成胶原蛋白和细胞外基质。PN HPT成分还有进一步的益处,即具有真皮“启动”效应,可增强其他瘢痕治疗的疗效。

目的

采用先进技术回顾性验证PN HPT单一疗法作为术后瘢痕治疗的疗效。

方法

对年龄在18至65岁、乳房手术后有中度至重度萎缩性瘢痕的女性进行回顾性数据收集,这些女性在术后6个月开始接受为期五疗程的皮内治疗,使用一次性注射器注射0.75%的PN HPT凝胶制剂。主要回顾性疗效参数:术后3个月和6个月时瘢痕形态和症状严重程度的变化(改良温哥华瘢痕量表,mVSS)。次要疗效参数:基线后6个月的粗糙度评分(Antera 3D CS三维皮肤分析系统)以及术后3个月和6个月的整体美学改善量表(GAIS,研究者和患者子量表)。

结果

mVSS总分均值从基线时的11.2±1.92显著改善至术后3个月时的7.0±1.68以及6个月时的6.9±1.55;6个月后,Antera 3D CS粗糙度评分均值从13.5±4.14改善至10.0±3.49。术后3个月和6个月时,研究者和队列受试者的GAIS子评分相同(分别为3.0±0.81和3.0±0.72)。照片记录支持了先前的结果。

结论

在单一疗法中,皮内注射PN HPT成分似乎能快速、安全地减轻术后萎缩性瘢痕的负担。然而,缺乏正式的平行对照组是一个严重的局限性。客观的定量测量证实了其长期益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89f/11734378/e4e6b478e141/JOCD-24-e16764-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验